Skip to main content
OpenTrials

Clinical trial condition

Colorectal Cancer

Explore clinical trials studying Colorectal Cancer. Study availability and eligibility vary by location and protocol.

2,501 public trials 464 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Cancer trial results

Recruiting

Evaluation of XYA02 in Patients With Advanced Solid Tumors

NCT07670312

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +38 more
Locations
  • Chris O'Brien Life House Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Monash Medical Centre Melbourne, Victoria, Australia
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

NCT07659795

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
View all 18 locations
View Trial Details
Recruiting

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

NCT06428409

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +13 more
Locations
  • UCLA ( Site 0317) Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus ( Site 0299) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0325) Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus ( Site 0326) Aurora, Colorado, United States
View all 55 locations
View Trial Details
Recruiting

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

NCT07525206

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Astera Cancer Care /ID# 279532 East Brunswick, New Jersey, United States
  • Northwell Health Center for Advanced Medicine. /ID# 279590 Lake Success, New York, United States
  • Compass Oncology - Rose Quarter /ID# 280127 Portland, Oregon, United States
  • University Of Washington-Fred Hutchinson Cancer Center - Seattle /ID# 281451 Seattle, Washington, United States
View all 81 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details
Recruiting

A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.

NCT07653685

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Gansu Provincial Tumor Hospital Lanzhou, Gansu, China
  • Guangxi Zhuang Autonomous Region Cancer Hospital Nanning, Guangxi, China
  • The Affiliated Hospital of Zunyi Medical University Zunyi, Guizhou, China
View all 31 locations
View Trial Details

Related conditions